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 Traditionally, the newt has been hailed as the most pow-
erful animal model for lens regeneration [1,2]. True enough,
adult newts always replace their lens following removal. Lens
regeneration in newts is achieved by transdifferentiation of
the pigment epithelial cells from the dorsal iris. Other am-
phibia, such as frogs, are capable of lens regeneration by
transdifferentiation of the cornea, but only during a short win-
dow of time before metamorphosis [3]. The situation in higher
vertebrates, especially in mammals, is very different. Lens
regeneration has been shown in rabbits, but only if the lens
capsule is left behind [4]. Obviously, some lens epithelial cells
remain attached to the lens capsule and they differentiate to
lens fibers to “regenerate” a lens, which nevertheless is not
perfect. Some similar, but limited, observations have been seen
in cats [5]. The studies with rabbits suggest that while lens
regeneration does not follow the same traditional road of
transdifferentiation as in newts, regeneration can nevertheless
occur by differentiation of lens epithelial cells remaining on
the capsule. Rabbits (or cats), however, are not favorable mam-
malian animal models for approaching the problem of lens
regeneration with the frontline technology of molecular biol-
ogy and, therefore, extensive studies at the molecular level
are hindered. We reported previously that when the lens is
removed in adult mice, leaving the capsule in the eye cavity,
lens fibers rapidly differentiate from the adherent lens epithe-
lial cells and fill the capsule within a few weeks, and is not
limited to Soemmerring’s ring only [6]. Such “regeneration”
of the lens is quite remarkable and has been reported in mouse
and rats by others as well [7,8]. Importantly, epithelial to mes-
enchymal transition (EMT) has been observed at the initial
stages in mice undergoing regeneration, indicating that the
process undergoes an initial phase of repair and of lens differ-
entiation.
EMT is a prominent process after cataract surgery. Dur-
ing modern cataract surgery, extracapsular lens removal al-
lows the synthetic lens to be placed on the remaining capsule.
However, adherent lens epithelial cells (LECs) still persist in
most cases. LECs tend to transdifferentiate to mesenchymal
cells, and this process leads to the so-called posterior capsule
opacification (PCO), which requires expensive laser treatment,
even though such procedures have been considerably reduced
recently because of the state of the art instruments and the
techniques applied [9]. The most common experimental pro-
cedures to study EMT in LECs are either treating LECs in
vitro or to injure lenses in vivo. Both rats and mice are com-
monly used for this assay. The in vivo procedure is usually
performed by injury of the anterior subcapsular region with a
needle. Such injury leads to cataract-related changes involv-
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ing EMT. Culture of capsular bags from humans is another
experimental system where proliferation and
transdifferentiation of LECs can be studied [10]. In these ex-
periments, the capsular bags from deceased donors can be
placed in culture, and the degree and development of EMT
can be assessed in vitro. Such studies have provided impor-
tant information about the factors involved, but are limited
for genetic manipulations. TGF-β is considered an important
factor in the initiation of EMT [11-13].
The ability of mice to regenerate the lens under the out-
lined conditions provides us with a valuable animal model
system to study basic biology of EMT at the molecular level
and to identify targets that eventually could lead to further
understanding of the medical complications and the design of
effective treatments. The availability of mutant mice and
microarray analysis enables us to profile genomic activity
during EMT, which is otherwise impossible to carry out. Fur-
thermore, such studies as the ones presented here might eluci-
date factors that will improve the quality of the regenerated
lens, information that will be important in future applications
when the lens is accidentally damaged. In the present study,
we have examined gene expression during different stages of
lens regeneration in mice via microarray hybridization and
analysis. Our results provide unique and interesting insights
in gene regulation during EMT and lens differentiation.
METHODS
Surgical procedures:  C57BL mice (six to eight months old)
were anesthetized with either intraperitoneal or subcutaneous
injections of ketamine (87 mg/kg) and xylazine (13 mg/kg).
Mice were also subcutaneously given the analgesic
buprenorphine (2 mg/kg) preemptively. Pupils were dilated
with the use of 1% tropicamide and 2.5% phenylephrine hy-
drochloride. A corneal incision was made, and anterior
capsulotomy was performed. The lens was then removed by
pushing the eye cavity with forceps. The anterior chamber was
filled with sodium hyaluronate. In our hands, this procedure
effectively removes the whole lens (we have examined re-
moved lenses and lentectomized eyes by histology) and leaves
the capsule behind, eventually with LECs. Figure 1 shows the
morphology of the capsule one day after lens removal.
Experimental design:  Microarray hybridization methods
were used to obtain global gene expression profiles from in-
tact and regenerating eyes after extracapsular lens removal in
C57BL mice eight weeks of age. We examined four times,
time 0 at the time of lens removal and 1, 2, and 3 weeks after
surgery. In our previous publication [6] we presented a histo-
logical study of the early stages of these events. During week
one we observed fiber differentiation and EMT. Week two was
basically marked by increased fiber differentiation and a lower
degree of EMT. By week three, EMT was virtually absent.
Since the goal of this study was to identify genes that affect
EMT and lens fiber differentiation, these times were suffi-
cient because both EMT and fiber differentiation occur rap-
idly after surgery and follow a particular course.
A 70-mer oligonucleotide library from Operon Technolo-
gies, Inc. (Huntsville, AL) representing 24,878 known mouse
genes (e.g., genes involved with cell signaling, apoptosis, cell
proliferation, etc.; including most, if not all, of the available
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Figure 1. Histological section through a capsular bag one day post-
lentectomy. The arrowhead marks where some cells remain at the
posterior (Post) area of the capsule. The arrow indicates the anterior
(Ant) part of the capsule.
Figure 2. Experimental design for the microarray studies. The indi-
cated time periods of 1, 2, and 3 represent weeks post-lentectomy
from time 0 (Control). Each mouse represents a biological replica
for a given experimental condition. An arrow denotes a microarray
slide comparison between a given pair of mice. Arrows for a given
experimental comparison represent “dye flips”. Our statistical model
does indeed unequivocally factor out the gene-specific dye effect
from the estimates of differential expression. This is achieved by
fitting a linear statistical model with a “dye” effect, as described in
the data normalization and analysis section of the methods, to each
gene separately. This approach has been demonstrated to work well
in unbalanced situations such as the week 2 and 3 comparisons [35].
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known genes involved in regeneration) were used for the
microarray experiments.
As depicted in Figure 2, each regenerating tissue was di-
rectly compared to the corresponding intact tissue. RNA from
control tissues was obtained from four independent animals
and hybridized with RNA obtained from the same number of
independent animals at week one and three animals at weeks
two and three after the surgery. Biological variation was ac-
counted for by including the multiple biological replicates per
experimental condition. Our statistical model does indeed
unequivocally factor out the gene-specific dye effect from the
estimates of differential expression. This is achieved by fit-
ting a linear statistical model with a “dye” effect, as described
in the data normalization and analysis section of the methods,
to each gene separately. This approach has been demonstrated
to work well in unbalanced situations such as the week two
and three comparisons.
Isolation of tissues and total RNA:  Total RNA was iso-
lated by standard methods using the Nucleospin RNA purifi-
cation kit from BD Bioscience (San Jose, CA). We analyzed
the quality of mRNA using an Agilent Bioanalyzer 2100 and
NanoDrop 1000.
Target labeling:  For each hybridization experiment (a
microarray slide), total RNA from two single animals were
used. Approximately 10 µg of total RNA was used for each
Cy-3 or Cy-5 labeling procedure. cDNA target was synthe-
sized using an indirect labeling method, in which aminoallyl-
dUTP (7:3 ratio of aa-dUTP:TTP) was incorporated in the
cDNA via an oligo(dT) primed reaction by reverse transcriptase
(Superscript III; Invitrogen, Carlsbad, CA). The cDNA was
decorated with Cy-3 and Cy-5 (Cy Dye™ Post-Labeling Re-
active Dye Packs; Amersham, GE Healthcare, Piscataway, NJ)
following the accompanying instructions. When necessary, the
RNA was amplified using the Amino Allyl MessageAmp™
kit from Ambion (Austin, TX), which in our hands produced
approximately 50-120 µg of amplified RNA (aRNA) with the
incorporated amino allyl nucleotides starting from one µg of
total RNA (10 µg of each aRNA was used per slide). The aRNA
is an accurate representation of the original total cellular RNA
[14].
Microarray hybridization:  The mouse 70-mer oligonucle-
otides were suspended in 3X SSC at 30 µM and printed at 22
°C and 65% relative humidity on aminosilane-coated slides
(VSA-25C; Cel Associates, Inc. Pearland, TX) using a high-
speed robotic OmniGrid machine (GeneMachines; San Carlos,
CA) with Stealth SMP3 pins (Telechem, Sunnyvale, CA)
[15,16]. The microarray slides were placed in prehybridization
buffer (5X SSC, 0.1% SDS, and 1% BSA) and incubated at
48 °C for 45-60 min. The slides were washed twice in deion-
ized water and used immediately for hybridization (2X hy-
bridization buffer: 50% formamide, 10X SSC, and 0.2% SDS).
The Cy-3 and Cy-5 labeled targets were suspended in nine µl
water and heated at 95 °C for 3 min. The following were added
to each tube of labeled target to inhibit nonspecific hybridiza-
tion: eight µl of 1 mg/ml COT1-DNA (Roche Diagnostics,
Basel, Switzerland), two µl of 10 mg/ml poly(A)-DNA (Sigma,
St. Louis, MO), and two µl of 4 mg/ml yeast tRNA (Sigma).
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Figure 3. Heat map from the cluster analysis of 2,094 differentially
expressed genes. The hierarchical clustering of all genes with each
line representing expression levels for a gene as compared to control
and each column a time (1, 2, and 3 weeks post-lentectomy). Shades
of red indicate increased expression and the shades of green decrease.
Genes are grouped according to a particular expression pattern (i.e.,
upregulation or downregulation) and within these two groups in other
sub-groups, such as strong uniform upregulation, strong uniform
downregulation, etc. Five clusters of co-expressed genes outlined in
the figure were statistically significantly enriched for genes in at least
one GO category.
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Next, 21 µl of 2X hybridization buffer preheated to 48 °C was
added to the target mixture, mixed well, and centrifuged. The
labeled target was applied to the prehybridized microarray
slides, covered with a 22x60 mm glass cover slip, and placed
in a sealed hybridization chamber (Corning, Acton, MA). The
sealed chamber was placed in a 48 °C water bath and incu-
bated for 40-60 h. For the posthybridization washes, the cov-
erslips were removed in 1X SSC, 0.1% SDS, and 0.1 mM
DTT at 48 °C, and the slides were agitated for 15 min. The
microarray slides were transferred to a staining dish contain-
ing 0.1X SSC, 0.1% SDS, and 0.1 mM DTT at 48 °C and
agitated for 5 min. The aforedescribed wash was repeated two
more times. The slides were then washed two times in 0.1X
SSC and 0.1 mM DTT at room temperature and agitated for 5
min. The slides were then spin dried [17].
Scanning and data generation:  Imaging was carried out
using a GenePix 4000A and GenePix 4000B (Axon Instru-
ments, Union City, CA) with GenePixPro 5.0 software. Im-
ages were captured in JPEG and TIFF files, and the DNA
probes were measured by the adaptive circle segmentation
method. Information extraction for a given spot was calcu-
lated using the median value for the signal pixels minus the
median value for the background pixels to produce a gene set
data file for all the DNA spots. The Cy-3 and Cy-5 fluores-
cence signal intensities were normalized by adjusting total fluo-
rescence levels.
Data normalization and analysis:  The data representing
raw spot intensities generated by GenePix® Pro version 5.0
was analyzed to identify differentially expressed genes. Data
normalization was performed in three steps for each microarray
separately [17]. First, channel-specific local background in-
tensities were subtracted from the median intensity of each
channel (Cy3 and Cy5). Second, background adjusted inten-
sities were log-transformed and the differences (R) and aver-
ages (A) of log-transformed values were calculated as
R=log2(X1/X2) and A=[log2(X1 X2)]/2, where X1 and X2
denote the Cy5 and Cy3 intensities after subtracting local back-
grounds, respectively. Third, data centering was performed
by fitting the array-specific local regression model of R as a
function of A. The difference between the observed logarith-
mic ratio and the corresponding fitted value represented the
normalized log-transformed gene expression ratio. Normal-
ized log-intensities for the two channels were then calculated
by adding half of the normalized ratio to A for the Cy5 chan-
nel and subtracting half of the normalized ratio from A for the
Cy3 channel. A statistical analysis was performed for each
gene separately by fitting the following mixed effects linear
model. Yijk=µ+Ai+Ck+Tj+εijk, where Yijk corresponds to the
normalized log-intensity on the ith array (i=1,...,10), at the jth
time (j=1,2,3), and labeled with the kth dye (1 for Cy5 and 2
for Cy3). µ is the overall mean log-intensity, Ai is the effect of
the ith array, Tj is the effect of the jth time, and Ck is the effect of
the kth dye. Assumptions about model parameters were the
same as described in the literature [18] with array effects as-
sumed to be random and treatment and dye effects assumed to
be fixed. Statistical significance of differential expression be-
tween RNA samples at each time after the treatment, after
adjusting for array and dye effects, was assessed by calculat-
ing p values and applying False Discovery Rates (FDR) mul-
tiple hypotheses testing [19,20]. Data normalization and sta-
tistical analyses were performed using SAS statistical soft-
ware package (SAS Institute Inc., Cary, NC).
Cluster analysis:  Clustering was performed with the
Bayesian infinite mixture (BIM) model-based clustering for
replicated microarray data [21,22] using replicated normal-
ized logarithmic ratios from each microarray. BIM model-
based clustering allowed for the fitting of the statistical mix-
ture model without knowing the number of clusters in the data
[22]. The statistical model was fitted using the Gibbs sampler,
and hierarchical clustering was produced by treating pair-wise
posterior probabilities as the similarity measure and applying
the traditional average-linkage principle. The clustering re-
sults were displayed using the TreeView program [23].
Functional clustering:  Clusters of co-expressed gene
identified by the cluster analysis were correlated with func-
tional groupings defined by Gene Ontologies (GO) [24]. Clus-
ters of genes with significantly over-represented genes from
specific GO categories were identified using the EASE soft-
ware [25]. Statistical significance of over-representation of
genes from a cluster in any given GO category was assessed
using the Fisher’s exact test with the Benjamini-Hochberg
adjustment for multiple hypothesis testing [19]. A GO cat-
egory was considered to be significantly associated with a clus-
ter if it contained more than one gene from the cluster and the
adjusted Fisher’s exact p value was less than 0.1.
Quantitative real-time polymerase chain reaction:  RNA
was isolated from intact eyes and eyes undergoing lens regen-
eration using Tri Reagent® (Molecular Research Center, Inc.,
Cincinnati, OH) according to the manufacturer’s instructions.
RNA (0.75 µg) was used to synthesize cDNA using the
iScript™ cDNA Synthesis Kit (BioRad). All Real-Time PCRs
were performed using the iCycler™ (BioRad). For each Real-
Time PCR reaction run in triplicate, 2 µl of cDNA, 800 nM
primers, and iQ™ SYBR® Green Supermix (BioRad) were
used. The data were analyzed using the Pfaffl method [26].
RESULTS & DISCUSSION
 Labeled target representing mouse mRNA from lens was used
to hybridize to arrayed 70-mer probes representing nearly
25,000 mouse genes. Gene expression profiles of regenerat-
ing lens (one, two, and three weeks post-lentectomy) were
compared to the expression profiles of intact lens (Figure 1).
We identified the genes that were significantly differentially
expressed during the regeneration process. In all, we identi-
fied 2,094 genes that showed regulation during regeneration
(FDR<0.05 in at least one comparison). Six clusters of co-
expressed genes defining distinct patterns of expression were
significantly correlated with at least one GO category
(FDR<0.1 and more than one gene from a cluster was a mem-
ber of a given GO category).
 A general pattern emerged indicating that during the first
week post-lentectomy, there was an increase in RNA levels of
genes involved in tissue repair, inflammation, and reorganiza-
tion of the cytoskeleton and the extracellular matrix (Figure
©2006 Molecular VisionMolecular Vision 2006; 12:422-40 <http://www.molvis.org/molvis/v12/a49/>
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TABLE 1.
                                                                          Fold changes
 GenBank                                                 Average    ------------------------
accession                  Gene name                   expression   Week 1   Week 2   Week 3
---------   ----------------------------------------   ----------   ------   ------   ------
J05605      Thrombospondin 1 precursor                      45       1.45    15.23     3.24
X81627      Neutrophil gelatinase-associated               141       4.26     5.27     6.93
            lipocalin precursor
X51547      P lysozyme structural                         3781       3.39     6.76     3.43
M33960      Serine (or cysteine)                           436       5.49     4.13     3.46
            proteinase inhibitor
AF071068    Dopa decarboxylase                            1379       2.92     6.17     3.16
BC002069    Lysozyme                                     14018       3.63     5.29     3.12
AK018742    Procollagen, type VIII, alpha 1                481       1.55     7.62     2.75
M26498      Endothelin-2 precursor                        1809       5.69     2.26     2.56
AK048616    Similar To Cdna Flj10680                        40       1.02     8.41     1.01
BC013651    Serine (or cysteine) proteinase               3583       3.96     2.44     3.54
            inhibitor, clade A, member 3N
D90343      Tenascin C                                     351       5.24     2.11     1.93
AK003674    Collagen triple helix repeat                  2832       4.92     2.4      1.8
            containing 1
BC006783    Connective tissue growth factor               3595       2.64     3.9      2.51
U49430      Ceruloplasmin                                  968       2.32     4.01     2.39
M17243      Tissue inhibitor of metalloproteinase 1        888       3.27     2.62     2.75
AJ223208    Cathepsin S                                    910       2.59     3.24     2.62
BC030071    Calcitonin/calcitonin-related                  128       2.33     2.89     3.05
            polypeptide, alpha
X97650      Myosin IF                                     1796       3.37     2.49     2.32
BC016551    Macrophage scavenger receptor 2                330       1.83     3.29     2.83
AF077829    TYRO protein tyrosine kinase                   937       1.88     3.61     2.4
            binding protein
AF213458    Cytochrome P450 4F 18                          356       2.54     2.65     2.68
AF213458    Triggering receptor expressed on               745       1.67     3.42     2.75
            myeloid cells 2b
L04264      Protein-lysine 6-oxidase precursor            3220       4.57     1.69     1.51
AF061272    C-type lectin                                  303       2.22     3.42     2.08
X58861      Complement component 1, q                     1652       1.73     3.56     2.38
X60929      Low affinity Ig gamma Fc region                398       2.28     3.02     2.34
            rec. III pre.
M73490      Apolipoprotein E                              3890       1.63     3.83     2.15
BC027425    Membrane-spanning 4-domains                    907       3.53     2.43     1.57
BC021539    Allograft inflammatory factor 1                557       3.01     2.75     1.74
AK010252    Leucine-rich repeat-containing 2               553       2.96     2.27     2.24
U47327      Histocompatibility 2                           104       1.15     3.76     2.52
AF175282    Disintegrin-like and metalloprotease           431       2.65     2.69     1.93
            with thrombospondin
U05264      Glycoprotein 49 B                             1722       2.31     2.55     2.37
AF290914    Stabilin 1                                     547       2.68     2.85     1.69
X92959      Complement C1Q subcomponent                   3207       2.24     2.76     2.2
D13664      Osteoblast specific factor 2                  1752       3.61     1.87     1.71
X93035      Chitinase 3-like 1                            6450       1.89     3        2.27
AK004165    Regulator of G-protein signaling 5             148       1.66     3.79     1.69
U42327      Vascular cell adhesion                        1972       2.63     2.02     2.44
            protein 1 precursor
M18524      H-2 class I histocompatibility antigen         328       1.43     3.16     2.47
AK018713    Cytochrome b-245                               699       1.57     2.9      2.57
M69069      Histocompatibility 2, D region locus 1         301       1.11     3.63     2.28
AK014036    Brca1 interacting protein                       48       1.11     4.31     1.54
M64866      Thrombospondin 2                              2412       3.79     1.34     1.75
AK033376    Similar to Acetyl-Coa Synthetase               114       1.41     3.61     1.84
Y11758      Biglycan                                      3736       2.19     2.28     2.35
U83172      Paired-Ig-like receptor B                     1662       3.35     2.16     1.28
AF063937    Serine (or cysteine) proteinase                371       4.35     1.39     1.04
            inhibitor, CLADE B
L33416      Extracellular matrix protein 1               11967       2.74     2.07     1.96
X92960      Complement C1Q subcomponent,                  3030       2.22     2.27     2.19
            C chain precursor
AF053757    C3A anaphylatoxin chemotactic receptor         272       2.93     2.49     1.20
Top 50 genes with the greatest increase in relative mRNA expression levels of regenerating lens compared to intact control lens 1, 2, and 3
weeks post-extracapsular surgery. For a better visual presentation of the regulated genes at 1, 2, and 3 weeks, the times that each gene is
highest is marked in red. 426
3). On the other hand, there was a significant decrease in RNA
levels of genes encoding lens structural proteins, such as
crystallins and other lens-fiber specific markers. As differen-
tiation and growth of the lens ensued, some of the differen-
tially expressed genes gradually returned to control levels of
expression. The profile of the crystallins indicated that their
synthesis followed the normal developmental program. At the
same time, we observed that some genes never reached con-
trol levels. Another interesting and novel discovery from the
clustering analysis was that RNA levels decreased for genes
©2006 Molecular VisionMolecular Vision 2006; 12:422-40 <http://www.molvis.org/molvis/v12/a49/>
TABLE 2.
                                                                           Fold changes
 GenBank                                                 Average     ------------------------
accession                   Gene name                   expression   Week 1   Week 2   Week 3
---------   -----------------------------------------   ----------   ------   ------   ------
BC021649    cAMP responsive element binding protein 1      6892      -13.62   -18.28   -13.79
NM_153601   Glutamate-ammonia ligase                      19389      -17.18   -15.45   -11.07
NM_178922   Hypermethylated in cancer 2 protein             317       -7.66   -14.77    -8.49
AF104312    Hydroxyacid oxidase 1, liver                    129       -3.94   -14.38   -11.74
S83259      Homeobox protein NKX-2.2                       1773       -9.73   -10.93    -8.02
BC004700    Kruppel-like factor 7                         12179      -10.64   -10.48    -4.57
Y13606      Beaded filament structural protein in          6252       -7.96    -9.24    -7.53
            lens-CP94
S81982      Nitric-oxide synthase, brain                   1606       -7.95    -8.12    -4.76
M64544      Crystallin, gamma C                            4184      -15.98    -1.72    -2.21
AF349659    Thioredoxin reductase 3                        1971       -7       -6.86    -5.46
AF047542    Cytochrome P450                               13609       -4.26   -10.12    -3.32
U21110      Signal transducer and activator of             5124      -10.98    -4.58    -1.7
            transcription 5B
AJ304860    Phakinin                                        868       -5.49    -5.83    -3.85
AF309072    Lactase-like                                   1556       -4.41    -6.68    -3.57
BC025817    FAD-synthetase                                13552       -6.18    -4.78    -3.57
AJ272229    Crystallin, beta B3                           13126       -4.46    -6.07    -3.67
AF277385    Prostatic steroid binding protein C1            204       -1.11    -11.03   -1.97
AF320075    Lens fiber membrane intrinsic protein          1709       -4.89    -5.21    -3.65
AJ239052    Crystallin, beta A1                           31909       -2.24    -8.16    -2.85
NM_172635   Expressed sequence AV312086                     543       -3.68    -5.65    -3.85
AF072881    WD-40-repeat-containing protein                 930       -2.31    -5.98    -4.84
AK053869    Crystallin, beta B1                           13272       -4.78    -4.99    -3.05
U36576      Nuclear factor of activated T-cells            1711       -3.39    -5.66    -3.73
U08095      Keratin, type cytoskeletal 12                 27443       -8.61    -2.43    -1.69
AK031386    Molecule interacting with Rab13                  69        1.16    -9.99    -3.74
AF334607    Dnase2-like acid Dnase                          289       -3.9     -6.36    -2.26
AJ224342    Gamma crystallin D                            33050       -7.29    -3.29    -1.61
Z22573      Gamma crystallin B                            36961       -8.33    -1.53    -2.06
AK003904    Ars component B                               13252       -6.75    -3       -1.41
AB037890    Splicing factor 3b                             2464       -4.46    -3.59    -2.54
U03562      Heat shock protein 1                          11548       -4.09    -2.97    -3.2
AF099938    Complement component C1Q                        901       -3.38    -2.72    -3.83
AF000143    Lens fiber major intrinsic protein             2291       -2.93    -4.93    -1.76
BC032251    Brain-specific angiogenesis inhibitor 3         395       -1.76    -4.57    -3.19
K02586      Gamma crystallin A                            12401       -1.83    -5.2     -2.36
BC002008    Fatty acid binding protein 5                  14299       -3.48    -3.26    -2.42
            Mkiaa1450 Protein                               118       -2.48    -3       -3.29
            sodium shannel                                 1395       -2.99    -3.29    -2.38
BC022920    Expressed sequence AA408140                    3694       -2.22    -3.5     -2.88
AB016768    R-spondin, thrombospondin-1-like domain         123       -3.03    -3.11    -1.84
X52128      T-complex protein 11                            246       -1.71    -3.99    -2.11
AK037164    Translation initiation factor                  1597       -2.17    -2.93    -2.67
BC024653    O-acyltransferase                              2740       -1.81    -3.3     -2.4
NM_172296   Doublesex and mab-3                             386       -1.95    -2.91    -2.46
AF020772    Karyopherin (importin) alpha 3                  318       -1.15    -4.75    -1.39
L14569      Olfactory receptor 7B                            43        1.05    -5.11    -3.22
D14423      Tachykinin 2                                    572       -2.06    -3.38    -1.81
AF156979    Arrestin 3                                     2920       -2.22    -2.72    -1.8
AY158991    Small proline-rich protein 2G                   698       -1.81    -3.02    -1.86
BC012704    Carbonic anhydrase 4                           9297       -2.21    -2.63    -1.81
AF032115    DnaJ (Hsp40) homolog                           2192       -2.32    -2.55    -1.77
Top 50 genes with the greatest decrease in relative mRNA expression levels of regenerating lens compared to intact control lens 1, 2, and 3
weeks post-extracapsular surgery. For a better visual presentation of the regulated genes at 1, 2, and 3 weeks, the times that each gene is lowest
is marked in red.
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TABLE 3.
                      Number
                     of genes                                          False
                      in the                                         discovery
 Main GO category    category             Gene category                rate
------------------   --------   ----------------------------------   ---------
Biological Process      10      Defense response                      8.2E-03
                        10      Response to biotic stimulus           1.6E-02
                         4      Chemotaxis                            3.3E-02
                         4      Taxis                                 3.3E-02
                         3      Cellular defense response             5.3E-02
                         7      Immune response                       7.9E-02
                         2      Antigen processing                    7.9E-02
                         4      Response to wounding                  7.9E-02
                         4      Response to chemical substance        7.9E-02
                        11      Response to external stimulus         7.9E-02
Cellular Component      31      Extracellular                         3.9E-06
                        28      Extracellular space                   9.1E-06
                         7      Lytic vacuole                         1.7E-04
                         7      Lysosome                              1.7E-04
                         7      Vacuole                               3.1E-04
                         2      Histone acetyltransferase complex     7.9E-02
Molecular Function       3      Cytokine binding                      3.5E-02
                         5      Cytokine activity                     4.6E-02
                         2      Interleukin receptor activity         7.9E-02
                         2      Interleukin binding                   7.9E-02
                         2      Chemokine receptor binding            7.9E-02
                         2      Chemokine activity                    7.9E-02
                         3      Exopeptidase activity                 7.9E-02
                         2      Chemoattractant activity              7.9E-02
                         2      G-protein-coupled receptor binding    8.5E-02
                         2      Growth factor binding                 9.6E-02
                         2      Carboxypeptidase activity             9.6E-02
                         6      Receptor binding                      9.6E-02
Gene ontology (GO) categories of the gene cluster displaying a weak uniform increase in relative mRNA levels of regenerating lens compared
to intact control lens.
involved in transcription and protein synthesis and may be a
key early event.
The overall pattern clearly follows two different biologi-
cal processes that take place after the extracapsular operation.
In the initial stages, there is EMT and considerable remodel-
ing of the extracellular matrix. At later stages, a lens differen-
tiation program takes over due to regeneration of lens fibers.
This observation is also clear from a list of the top 50 differ-
entially expressed genes that showed the greatest increase in
mRNA levels across the different times after surgery relative
to control lens (Table 1). Thrombospondin-1 (TSP-1) precur-
sor showed the greatest fold-change increase. TSP-1 is a gly-
coprotein involved in the activation of TGF-β, which is con-
sidered to be the main inducing factor of EMT [27]. TSP-1
has been shown to accumulate during PCO and decline dur-
ing fiber differentiation [27]. Other highly upregulated genes
encode proteins that are involved in matrix remodeling, such
as procollagen, TIMP-1, cathepsin, tenascin C, proteinases,
and leucine-rich repeat containing protein (Table 1). Among
the 50 genes that showed the greatest decrease in mRNA lev-
els in the regenerating lens relative to the control (Table 2) are
genes that encode structural proteins of differentiated lens fi-
bers. The list includes several crystallins, phakinin, beaded
filament structural protein, lens fiber membrane intrinsic pro-
tein, and lens fiber major intrinsic protein. Also, several regu-
latory genes, such as the homeo box NKX-2.2, the Kruppel
factor 7, the cAMP responsive element binding protein, and
NFAT are clustered with the lens fiber-specific ones (Table 2).
In Table 1 and Table 2, the time with the highest (or lowest)
regulation is highlighted in red. This was designed to help the
reader to identify with a glance the times and the genes show-
ing the most regulation. Interestingly, it becomes obvious that
at week 2 we have the most severe regulation, positive or nega-
tive. These findings may eventually allow us to identify spe-
cific gene regulation programs involved in the distinct pro-
cesses of EMT and fiber differentiation that take place during
the process of mouse lens regeneration. The only genes that
also coincide with cataract loci are the crystallin genes.
We further examined five general patterns of expression
identified by correlating the clusters formed by the cluster
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TABLE 4.
 GenBank
accession   Symbol                                Description
---------   --------   ------------------------------------------------------------------
BC010275    Arpc1b     Actin related protein 2/3 complex, subunit 1B
M10416      B2m        Beta-2 microglobulin
U89399      Coro1a     Coronin, actin binding protein 1A
S70244      Clu        Clusterin
U56819      Ccr2       Chemokine (C-C motif) receptor 2
AF237721    Col9a3     Procollagen, type IX, alpha 3
AF039391    Crym       Crystallin, mu
S69034      Ctsb       Cathepsin B
U74683      Ctsc       Cathepsin C
D88689      Flt1       FMS-like tyrosine kinase 1
AF254441    Gcn5l2     GCN5 general control of amino acid synthesis-like 2 (yeast)
BC016431    Leprel2    Leprecan-like 2
X62321      Grn        Granulin
AF267747    Gtf2i      General transcription factor II I
BC034217    H13        Histocompatibility 13
AB013095    Hebp1      Heme binding protein 1
U07741      Hexb       Hexosaminidase B
X05429      Ii         Ia-associated invariant chain
U53696      Il10rb     Interleukin 10 receptor, beta
M20658      Il1r1      Interleukin 1 receptor, type I
D16313      Krt1-15    Keratin complex 1, acidic, gene 15
X03491      Krt2-4     Keratin complex 2, basic, gene 4
J03881      Lamp1      Lysosomal membrane glycoprotein 1
M32018      Lamp2      Lysosomal membrane glycoprotein 2
AJ243857    Lhx9       LIM homeobox protein 9
AF139987    Limk1      LIM-domain containing, protein kinase
M89956      Lsp1       Lymphocyte specific 1
AF004874    Ltbp2      Latent transforming growth factor beta binding protein 2
AK007774    Ltbp3      Latent transforming growth factor beta binding protein 3
AJ298054    Blnk       B-cell linker
U47737      Ly6e       Lymphocyte antigen 6 complex, locus E
M34094      Mdk        Midkine
L11625      Mertk      C-mer proto-oncogene tyrosine kinase
S77350      Mglap      Matrix gamma-carboxyglutamate (gla) protein
M77226      Muc1       Mucin 1, transmembrane
AK036379    Ncf2       Neutrophil cytosolic factor 2
X57337      Pcolce     Procollagen C-proteinase enhancer protein
M74227      Ppic       Peptidylprolyl isomerase C
AF065933    Ccl2       Chemokine (C-C motif) ligand 2
BC032922    Sla        Src-like adaptor
X57413      Tgfb2      Transforming growth factor, beta 2
J03299      Trf        Transferring
BC011182    Zfp39      Zinc finger protein 39
X76696      Cd52       CD52 antigen
AF358138    Hcst       Hematopoietic cell signal transducer
AJ249987    Taf10      TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated
                       factor
AK018587    Batf       Basic leucine zipper transcription factor, ATF-like
AK076162    Litaf      LPS-induced TN factor
AF290973    Ifi30      Interferon gamma inducible protein 30
BC005532    Cndp2      CNDP dipeptidase 2 (metallopeptidase M20 family)
AK029988    Cxcl16     Chemokine (C-X-C motif) ligand 16
AF219141    Agtpbp1    ATP/GTP binding protein 1
AF393640    Srpx2      Sushi-repeat-containing protein, X-linked 2
AK007397    Adh6a      Alcohol dehydrogenase 6A (class V)
AF345635    Pir        Pirin
AJ421478    Cnbp2      Cellular nucleic acid binding protein 2
BC034522    Oplah      5-oxoprolinase (ATP-hydrolysing)
BC048078    AI428855   Expressed sequence AI428855
BC022145    BC022145   cDNA sequence BC022145
BC013712    BC013712   cDNA sequence BC013712
BC027331    P2ry6      Pyrimidinergic receptor P2Y, G-protein coupled, 6
AK007226    Atp2c1     ATPase, Ca++-sequestering
AK028285    Sulf1      Sulfatase 1
AK047568    Snph       Syntaphilin
U29501      Zfp75      Zinc finger protein 75
BC028661    Myo1g      Myosin IG
BC025046    Cdk8       Cyclin-dependent kinase 8
The gene cluster displaying a weak uniform increase in relative mRNA levels of regenerating lens compared to intact control lens.
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analysis of gene expression profiles and functional clusters
based on GO categories.
Weak uniform increase in RNA levels:  In this group, the
clustered genes showed a general pattern of a relatively slight
increase in RNA levels throughout the regeneration process.
In Table 3, the genes are divided according to main GO cat-
egory, biological process, cellular component, and molecular
function. Table 4 presents a general feature of this subgroup
in that it contains genes involved in defense, response to in-
jury, and extracellular matrix metabolism and also includes
TGF-β and TGF-β-binding proteins, which are known me-
diators of EMT.
Strong uniform increase in RNA levels:  As in the previ-
ous group, the genes in this cluster showed a general increase
in RNA levels but more pronounced. These genes are involved
in immune response, adhesion and remodeling, and processes
that mediate injury and re-building of tissues after damage.
Thrombospondins and disintegrins are included in the list
(Table 5, Table 6).
Strong delayed increase in RNA levels:  The mRNA lev-
els of the genes in this group showed a sharp increase at week
2. Most of these genes are involved in cytoskeletal organiza-
tion and negative regulation of transcription (Table 7, Table
8).
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TABLE 5.
                      Number
                     of genes                                                    False
                      in the                                                   discovery
 Main GO category    category                  Gene category                     rate
------------------   --------   --------------------------------------------   ---------
Biological Process      17      Response to biotic stimulus                     1.0E-06
                        16      Defense response                                1.2E-06
                        14      Immune response                                 3.3E-06
                         7      Humoral immune response                         3.3E-06
                        10      Response to pest/pathogen/parasite              2.4E-05
                        18      Response to external stimulus                   3.9E-04
                         4      Complement activation                           1.6E-03
                        11      Cell adhesion                                   2.1E-03
                         4      Humoral defense mechanism (sensu Vertebrata)    2.3E-03
                         3      Antigen processing                              3.3E-03
                        11      Response to stress                              4.7E-03
                         3      Antigen presentation                            5.1E-03
                         3      Complement activation, classical pathway        5.1E-03
                         4      Angiogenesis                                    6.2E-03
                         4      Blood vessel development                        1.0E-02
                         2      Antigen presentation, exogenous antigen         1.2E-02
                         2      Antigen processing, exogenous antigen via       1.2E-02
                                MHC class II
                         2      Cell wall catabolism                            1.6E-02
                         2      Regulation of angiogenesis                      3.0E-02
                         2      Cytolysis                                       4.9E-02
Cellular Component      45      Extracellular                                   4.7E-11
                        41      Extracellular space                             2.0E-10
                        13      Extracellular matrix                            1.1E-06
                         2      Complement component C1q complex                1.9E-03
Molecular Function      10      Glycosaminoglycan binding                       7.9E-10
                         9      Heparin binding                                 5.7E-09
                         4      Complement activity                             4.3E-04
                         9      Cell adhesion molecule activity                 1.9E-03
                         6      Defense/immunity protein activity               1.9E-03
                         2      Lysozyme activity                               4.2E-03
                         3      Scavenger receptor activity                     9.5E-03
                         2      MHC class II receptor activity                  1.0E-02
                         5      Endopeptidase inhibitor activity                1.2E-02
                         5      Protease inhibitor activity                     1.2E-02
                         6      Enzyme inhibitor activity                       1.9E-02
                        10      Enzyme regulator activity                       1.9E-02
                         2      Integrin binding                                4.1E-02
                         2      Insulin-like growth factor binding              6.7E-02
                         2      Antimicrobial peptide activity                  6.7E-02
                        24      Signal transducer activity                      6.7E-02
Gene Ontology (GO) categories of the gene cluster displaying a strong uniform increase in relative mRNA levels of regenerating lens com-
pared to intact control lens.
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TABLE 6.
 GenBank
accession      Symbol                                Description
---------   -------------   -------------------------------------------------------------
BC021539    Aif1            allograft inflammatory factor 1
AF212924    Ank3            ankyrin 3, epithelial
U72941      Anxa4           annexin A4
M73490      Apoe            apolipoprotein E
Y11758      Bgn             Biglycan
X58861      C1qa            complement component 1, q subcomponent, alpha polypeptide
X92959      C1qb            complement component 1, q subcomponent, beta polypeptide
X92960      C1qg            complement component 1, q subcomponent, gamma polypeptide
AF053757    C3ar1           complement component 3a receptor 1
BC030071    Calca           calcitonin/calcitonin-related polypeptide, alpha
X07411      Cbr2            carbonyl reductase 2
BC004076    Ccnd3           cyclin D3
X93035      Chi3l1          chitinase 3-like 1
AK052963    Col14a1         procollagen, type XIV, alpha 1
U49430      Cp              ceruloplasmin
BC002072    Cst3            cystatin C
AJ006033    Ctsk            cathepsin K
AJ223208    Ctss            cathepsin S
AK018713    Cyba            cytochrome b-245, alpha polypeptide
AF071068    Ddc             dopa decarboxylase
L33416      Ecm1            extracellular matrix protein 1
M26498      Edn2            endothelin 2
AF135252    Fbln2           fibulin 2
X60929      Fcgr3           Fc receptor, IgG, low affinity III
BC006783    Ctgf            connective tissue growth factor
BC004647    Flot1           flotillin 1
BC004724    Fn1             fibronectin 1
AF149059    Gclm            glutamate-cysteine ligase, modifier subunit
U05264      Lilrb4          leukocyte immunoglobulin-like receptor, subfamily B, member 4
V01527      H2-Ab1          histocompatibility 2, class II antigen A, beta 1
M18524      H2-D1           histocompatibility 2, D region locus 1
M69069      H2-D1           histocompatibility 2, D region locus 1
M36939      H2-Eb1          histocompatibility 2, class II antigen E beta
X56790      Cyr61           cysteine rich protein 61
X81627      Lcn2            lipocalin 2
L04264      Lox             lysyl oxidase
BC002069    Lyzs            lysozyme
X51547      Lzp-s           P lysozyme structural
AF061272    Clecsf8         C-type (calcium dependent, carbohydrate recognition domain)
                            lectin, superfamily member 8
X97650      Myo1f           myosin IF
U83172      Pirb            paired-Ig-like receptor B
M33960      Serpine1        serine (or cysteine) proteinase inhibitor, clade E, member 1
D37837      Lcp1            lymphocyte cytosolic protein 1
AK002410    Plscr2          phospholipid scramblase 2
U33626      Pml             promyelocytic leukemia
AK079915    Lgals3bp        lectin, galactoside-binding, soluble, 3 binding protein
U57999      Psap            prosaposin
S72304      Rab34           RAB34, member of RAS oncogene family
AK004165    Rgs5            regulator of G-protein signaling 5
U58886      Sh3gl2          SH3-domain GRB2-like 2
BC013651    Serpina3n       serine (or cysteine) proteinase inhibitor, clade A, member 3N
X70946      Serpine2        serine (or cysteine) proteinase inhibitor, clade E, member 2
AK010442    Syngr1          synaptogyrin 1
M64866      Thbs2           thrombospondin 2
M17243      Timp1           tissue inhibitor of metalloproteinase 1
D90343      Tnc             tenascin C
AF077829    Tyrobp          TYRO protein tyrosine kinase binding protein
U42327      Vcam1           vascular cell adhesion molecule 1
AF175282    Adamts8         a disintegrin-like and metalloprotease (reprolysin type) with
                            thrombospondin type 1 motif, 8
D13664      Postn           periostin, osteoblast specific factor
AF350047    Rgs3            regulator of G-protein signaling 3
BC023008    Clecsf10        C-type (calcium dependent, carbohydrate recognition domain)
                            lectin, superfamily member 10
BC003482    Tm4sf7          transmembrane 4 superfamily member 7
AY082484    Ifitm3          interferon induced transmembrane protein 3
BC019764    Ube1dc1         ubiquitin-activating enzyme E1-domain containing 1
AK007397    Adh6a           alcohol dehydrogenase 6A (class V)
BC027425    Ms4a6b          membrane-spanning 4-domains, subfamily A, member 6B
AK010084    2310067E08Rik   RIKEN cDNA 2310067E08 gene
BC013494    Cyp4f18         cytochrome P450, family 4, subfamily f, polypeptide 18
AK008652    Ms4a6c          membrane-spanning 4-domains, subfamily A, member 6C
BC016551    Msr2            macrophage scavenger receptor 2
AF213458    Trem2           triggering receptor expressed on myeloid cells 2
BC026375    Gpnmb           glycoprotein (transmembrane) nmb
AJ308965    Psip1           PC4 and SFRS1 interacting protein 1
AF398968    Asb7            ankyrin repeat and SOCS box-containing protein 7
AK033038    Oosp1           oocyte secreted protein 1
AF290914    Stab1           stabilin 1
The gene cluster displaying a strong uniform increase in relative mRNA levels of regenerating lens compared to intact control lens.
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TABLE 7.
                      Number
                     of genes                                                False
                      in the                                               discovery
 Main GO category    category                Gene category                   rate
------------------   --------   ----------------------------------------   ---------
Biological Process      6       negative regulation of transcription        7.8E-02
                        5       negative regulation of transcription,       9.7E-02
                                DNA-dependent
                        9       cytoskeleton organization and biogenesis    9.7E-02




accession     Symbol                              Description
---------   -----------   ------------------------------------------------------------
U76732      Adh7          Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
U88623      Aqp4          Aquaporin 4
L07918      Arhgdib       Rho, GDP dissociation inhibitor (GDI) beta
AC002397    Bcap37        B-cell receptor-associated protein 37
D16432      Cd63          Cd63 antigen
M64278      Chga          Chromogranin A
X04591      Ckb           Creatine kinase, brain
AB033123    Ctbp2         C-terminal binding protein 2
X94998      Fmod          Fibromodulin
S71213      Gnai2         Guanine nucleotide binding protein, alpha inhibiting 2
M96645      Gp38          Glycoprotein 38
AF027505    Baiap1        BAI1-associated protein 1
D16464      Hes1          Hairy and enhancer of split 1 (Drosophila)
M10062      Iap           Intracisternal A particles
M60523      Idb3          Inhibitor of DNA binding 3
BC003804    Ifit3         Interferon-induced protein with tetratricopeptide repeats 3
AK011790    Igfbp2        Insulin-like growth factor binding protein 2
X69902      Itga6         Integrin alpha 6
M64228      Kcnb1         Potassium voltage gated channel, Shab-related subfamily,
                          member 1
AB023656    Kif1b         Kinesin family member 1B
AF202892    Kif21a        Kinesin family member 21A
D16313      Krt1-15       Keratin complex 1, acidic, gene 15
M13805      Krt1-17       Keratin complex 1, acidic, gene 17
U55060      Lgals9        Lectin, galactose binding, soluble 9
AF367720    Lrp1          Low density lipoprotein receptor-related protein 1
X66983      Mak           Male germ cell-associated kinase
AF047714    Trpm1         Transient receptor potential cation channel, subfamily M,
                          member 1
M36411      Mpv17         Mpv17 transgene, kidney disease mutant
AJ249706    Myo10         Myosin X
AK077116    Naga          N-acetyl galactosaminidase, alpha
X61450      Napb          N-ethylmaleimide sensitive fusion protein attachment protein
                          beta
X61455      Napb          N-ethylmaleimide sensitive fusion protein attachment protein
                          beta
S40532      Nhlh2         Nescient helix loop helix 2
AF219626    Ninj1         Ninjurin 1
AJ006803    Nrxn2         Neurexin II
U79523      Pam           Peptidylglycine alpha-amidating monooxygenase
AF023529    Pde1a         Phosphodiesterase 1A, calmodulin-dependent
BC005661    Pgam1         Phosphoglycerate mutase 1
L43371      Ppap2a        Phosphatidic acid phosphatase 2a
X58990      Ppib          Peptidylprolyl isomerase B
BC004730    Psmb10        Proteasome (prosome, macropain) subunit, beta type 10
AB001607    Ptgis         Prostaglandin I2 (prostacyclin) synthase
AK088005    Ptma          Prothymosin alpha
S52353      Ptn           Pleiotrophin
AK050418    Rp2h          Retinitis pigmentosa 2 homolog (human)
D43805      Cxcl12        Chemokine (C-X-C motif) ligand 12
432
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TABLE 8. Continued.
 GenBank
accession     Symbol                              Description
---------   -----------   ------------------------------------------------------------
M74773      Spnb2         Spectrin beta 2
U30709      Stat3         Signal transducer and activator of transcription 3
U55862      Tia1          Cytotoxic granule-associated RNA binding protein 1
M93954      Timp2         Tissue inhibitor of metalloproteinase 2
U41741      Usf1          Upstream transcription factor 1
U80078      Zfp148        Zinc finger protein 148
AJ316580    Mgll          Monoglyceride lipase
U43206      Pbp           Phosphatidylethanolamine binding protein
AF033116    Zfhx1b        Zinc finger homeobox 1b
AK020876    Nubp1         Nucleotide binding protein 1
AF128236    Psg18         Pregnancy specific glycoprotein 18
AB071988    H2afy         H2A histone family, member Y
AY133242    Ahi1          Abelson helper integration site
AF239886    Espn          Espin
AK010636    MGI:1929282   Telomerase binding protein, p23
BC007177    Ccnl1         Cyclin L1
BC014726    Sertad2       SERTA domain containing 2
AK088173    Nek7          NIMA (never in mitosis gene a)-related expressed kinase 7
AK075861    Sirt3         Sirtuin 3 (silent mating type information regulation 2,
                          homolog) 3 (S. cerevisiae)
BC031854    D14Ertd449e   DNA segment, Chr 14, ERATO Doi 449, expressed
AK009412    Srp19         Signal recognition particle 19
AK017655    Luc7l         Luc7 homolog (S. cerevisiae)-like
BC027328    Bst2          Bone marrow stromal cell antigen 2
AK005050    Dhdh          Dihydrodiol dehydrogenase (dimeric)
BC052406    Brunol6       Bruno-like 6, RNA binding protein (Drosophila)
AY055832    Mtmr2         Myotubularin related protein 2
BC002262                  Mus musculus expressed sequence AI428795, mRNA
AF130313    Nckipsd       NCK interacting protein with SH3 domain
BC021457    Slmap         Sarcolemma associated protein
AF252281    Klhl1         Kelch-like 1 (Drosophila)
AY013783    Pcdhb21       Protocadherin beta 21
AF296412    Aipl1         Aryl hydrocarbon receptor-interacting protein-like 1
AY078170    Dph2l1        Diptheria toxin resistance protein required for diphthamide
                          biosynthesis (Saccharomyces)-like 1
BC019406    Bbox1         Butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1
                          (gamma-butyrobetaine hydroxylase)
AF403039    MGI:2183445   SPRY domain-containing SOCS box 4
BC027170    C79267        Expressed sequence C79267
BC027407    Zfp472        Zinc finger protein 472
BC017130    Pja2          Praja 2, RING-H2 motif containing
BC003885    BC003885      cDNA sequence BC003885
BC027194    Golph3l       Golgi phosphoprotein 3-like
BC027279    Blvrb         Biliverdin reductase B (flavin reductase (NADPH))
AK044042    Cpne5         Copine V
AK075830    Usp7          UUbiquitin specific protease 7
AK030085    D2Ertd485e    DNA segment, Chr 2, ERATO Doi 485, expressed
The gene cluster displaying a strong increase in relative mRNA levels late during lens regeneration compared to intact control lens.
Weak early decrease in RNA levels:  The main character-
istic of this group was that the genes are involved in nucleic
acid biosynthesis and ribosomal function. This result suggests
that during the early events of repair, there is a general inhibi-
tion of transcriptional and translational events (Table 9, Table
10).
Strong uniform decrease in RNA levels:  The genes in this
cluster are involved in sensory organ development, percep-
tion of light, and the structural components of the lens (Table
11, Table 12). mRNA levels for the crystallins and other struc-
tural proteins of the lens, such as phakinin, are severely de-
creased indicating that lens fiber differentiation is not at its
final stages during the repair process. Naturally, the drop in
RNA levels of some genes in this group becomes less severe
with the later stages of lens fiber differentiation (3 weeks post-
lentectomy).
Verification of expression by quantitative real-time poly-
merase chain reaction:  We selected ten genes to verify their
expression by quantitative real-time polymerase chain reac-
tion (QPCR). The selected genes showed different patterns of
expression in the microarray experiments. TIMP1 showed a
strong uniform increase in RNA levels, lysozyme showed
strong increase at week 2, ceruloplasmin showed a weak uni-
form increase and γB-crystallin showed strong uniform de-
crease in RNA levels. Others showed not much variation and
had lower levels. Ratios observed in microarray experiments
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TABLE 9.
                      Number
                     of genes                                                   False
                      in the                                                  discovery
 Main GO category    category                  Gene category                    rate
------------------   --------   -------------------------------------------   ---------
Biological Process      16      Macromolecule biosynthesis                     2.9E-03
                        17      Biosynthesis                                   5.3E-03
                        12      Protein biosynthesis                           6.1E-03
                         2      RNA elongation                                 2.8E-02
                         3      Purine ribonucleoside triphosphate             5.3E-02
                                biosynthesis
                         3      Purine nucleoside triphosphate biosynthesis    5.3E-02
                         3      Ribonucleoside triphosphate biosynthesis       5.3E-02
                         7      Perception of abiotic stimulus                 5.3E-02
                         7      Sensory perception                             5.3E-02
                         3      Purine ribonucleoside triphosphate             5.3E-02
                                metabolism
                         3      Ribonucleoside triphosphate metabolism         5.3E-02
                         3      Nucleoside triphosphate biosynthesis           5.3E-02
                         5      Perception of chemical substance               5.3E-02
                         5      Chemosensory perception                        5.3E-02
                         3      Purine nucleoside triphosphate metabolism      5.3E-02
                        14      G-protein coupled receptor protein             5.8E-02
                                signaling pathway
                         7      Perception of external stimulus                5.8E-02
                         3      Purine ribonucleotide biosynthesis             5.8E-02
                         3      Nucleoside triphosphate metabolism             5.8E-02
                         3      Purine nucleotide biosynthesis                 6.9E-02
                         3      Ribonucleotide biosynthesis                    7.1E-02
                         2      Phosphoenolpyruvate-dependent sugar            7.6E-02
                                phosphotransferase system
                         3      Purine ribonucleotide metabolism               7.6E-02
                         3      Purine nucleotide metabolism                   7.8E-02
                         3      Ribonucleotide metabolism                      7.8E-02
                         2      Oxidative phosphorylation                      8.7E-02
                         2      ATP biosynthesis                               9.8E-02
                         2      Nucleoside phosphate metabolism                9.8E-02
Cellular Component      10      Ribosome                                       2.0E-03
                        12      Ribonucleoprotein complex                      2.0E-03
                        14      Mitochondrion                                  1.2E-02
                         3      Small ribosomal subunit                        5.3E-02
                         2      Transport vesicle                              5.3E-02
                         3      Organellar ribosome                            5.8E-02
                         3      Mitochondrial ribosome                         5.8E-02
                         3      Mitochondrial matrix                           9.8E-02
                         2      Mitochondrial large ribosomal subunit          9.9E-02
                         2      Organellar large ribosomal subunit             9.9E-02
Molecular Function      10      Structural constituent of ribosome             1.1E-03
                        13      Structural molecule activity                   1.7E-02
                        10      RNA binding                                    2.2E-02
                         4      Hydrogen ion transporter activity              7.8E-02
                         4      Monovalent inorganic cation transporter        7.8E-02
                                activity
                         2      Oxidoreductase activity, acting on heme        7.8E-02
                                group of donors, oxygen as acceptor
                         2      Cytochrome-c oxidase activity                  7.8E-02
                         2      Oxidoreductase activity, acting on heme        7.8E-02
                                group of donors
                         2      Heme-copper terminal oxidase activity          7.8E-02
                         2      DNA dependent ATPase activity                  8.1E-02
                         2      Damaged DNA binding                            9.7E-02
Gene ontology (GO) categories of the gene cluster displaying a weak decrease in relative mRNA levels early during lens regeneration com-
pared to intact control lens.
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TABLE 10.
 GenBank
accession     Symbol                               Description
---------   -----------   -------------------------------------------------------------
AF104416    Aqp3          aquaporin 3
BC011291    Arbp          acidic ribosomal phosphoprotein P0
X52940      Cox7c         cytochrome c oxidase, subunit VIIc
X53599      Fmn           formin
U38498      Gng5          guanine nucleotide binding protein (G protein), gamma 5
                          subunit
AF319526    Gstm2         glutathione S-transferase, mu 2
U96116      Hadh2         hydroxyacyl-Coenzyme A dehydrogenase type II
D63663      Pwwp1         PWWP domain containing 1
U60001      Hint1         histidine triad nucleotide binding protein 1
U12791      Hmgcs2        3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
AK004568    Rps2          ribosomal protein S2
X68193      Nme2          expressed in nonmetastatic cells 2, protein
AF102540    Olfr61        olfactory receptor 61
AK011242    Rad51         RAD51 homolog (S. cerevisiae)
AK012580    Rpl18         ribosomal protein L18
AK086805    Mrpl23        mitochondrial ribosomal protein L23
L08651      Rpl29         ribosomal protein L29
X80899      Cox7a2l       cytochrome c oxidase subunit VIIa polypeptide 2-like
AF042139    Ssa2          Sjogren syndrome antigen A2
BC010807    Tcea3         transcription elongation factor A (SII), 3
U60150      Vamp2         vesicle-associated membrane protein 2
BC037541    Lynx1         Ly6/neurotoxin 1
AF093260    Homer2        homer homolog 2 (Drosophila)
X76772      Rps3          ribosomal protein S3
AK008036    Atp5l         ATP synthase, H+ transporting, mitochondrial F0 complex,
                          subunit g
BC012241    Atp5o         ATP synthase, H+ transporting, mitochondrial F1 complex, O
                          subunit
AF177399    Dkkl1         dickkopf-like 1
BC011162    Ncald         neurocalcin delta
AF119676    Rab25         RAB25, member RAS oncogene family
AK002585    Fxyd1         FXYD domain-containing ion transport regulator 1
AK030225    Cyb561d2      cytochrome b-561 domain containing 2
AK014963    Xrcc2         X-ray repair complementing defective repair in Chinese
                          hamster cells 2
AF124425    Cldn10        claudin 10
AB024448    Jph2          junctophilin 2
AK028318    Sv2a          synaptic vesicle glycoprotein 2 a
AK018778    Gng13         guanine nucleotide binding protein 13, gamma
AK003225    Mrpl54        mitochondrial ribosomal protein L54
BC027511    Lsm7          LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)
AF230339    Znrd1         zinc ribbon domain containing, 1
AK003341    Chchd5        coiled-coil-helix-coiled-coil-helix domain containing 5
BC027546    Mrps21        mitochondrial ribosomal protein S21
AK028011    Ndufc1        NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1
AK010329    Mrpl11        mitochondrial ribosomal protein L11
BC024346    MGI:1913699   mitochondria-associated protein involved in GMCSF signal
                          transduction
AK088737    Rplp2         ribosomal protein, large P2
AK003223    Dpm3          dolichyl-phosphate mannosyltransferase polypeptide 3
AK003192    Ict1          immature colon carcinoma transcript 1
BC030905    Ascc1         activating signal cointegrator 1 complex subunit 1
AK008201    Ndufa11       NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11
AB093231    Tln2          talin 2
AY071834    Optn          optineurin
AK005562    Eml2          echinoderm microtubule associated protein like 2
AF319173    Psca          prostate stem cell antigen
AK006855    MGI:1920610   actin-related protein T1
BC016253    Man2c1        mannosidase, alpha, class 2C, member 1
AB046537    Pi16          protease inhibitor 16
AK049110    D15Ertd735e   DNA segment, Chr 15, ERATO Doi 735, expressed
AJ421478    Cnbp2         cellular nucleic acid binding protein 2
AK012695    Mgea5         meningioma expressed antigen 5 (hyaluronidase)
AK020927    Rdh12         retinol dehydrogenase 12
AB053477    Abtb1         ankyrin repeat and BTB (POZ) domain containing 1
AJ278462    Mmp1a         matrix metalloproteinase 1a (interstitial collagenase)
X04652      Hist2h4       histone 2, H4
AF425084    Serpinb6c     serine (or cysteine) proteinase inhibitor, clade B, member 6c
AF372838    Rdh9          retinol dehydrogenase 9
BC031759    MGI:2135937   SH3-binding kinase
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TABLE 11.
                      Number
                     of genes                                              False
                      in the                                             discovery
 Main GO category    category               Gene category                  rate
------------------   --------   --------------------------------------   ---------
Biological Process       7      Sensory organ development                 1.4E-09
                         7      Peripheral nervous system development     9.6E-09
                         5      Vision                                    9.0E-03
                         5      Perception of light                       1.1E-02
                         5      Response to light                         1.1E-02
                         5      Response to radiation                     1.4E-02
                         8      Neurogenesis                              1.5E-02
                         2      Mo-molybdopterin cofactor biosynthesis    1.6E-02
                         2      Mo-molybdopterin cofactor metabolism      1.6E-02
                         2      Pteridine and derivative biosynthesis     4.1E-02
                         2      Pteridine and derivative metabolism       4.8E-02
                         2      Aromatic compound biosynthesis            5.5E-02
Cellular Component      29      Cytoplasm                                 9.5E-02
Molecular Function       7      Structural constituent of eye lens        9.6E-09
Gene Ontology (GO) categories of the gene cluster displaying a strong uniform decrease in relative mRNA levels of regenerating lens com-
pared to intact control lens.
TABLE 12.
 GenBank
accession     Symbol                               Description
---------   -----------   -------------------------------------------------------------
AF072815    Aldh3a1       Aldehyde dehydrogenase family 3, subfamily A1
AF087654    Aqp5          Aquaporin 5
Y13606      Bfsp1         Beaded filament structural protein in lens-CP94
BC012704    Car4          Carbonic anhydrase 4
BC021649    Creb1         cAMP responsive element binding protein 1
TABLE 10. Continued.
 GenBank
accession     Symbol                               Description
---------   -----------   -------------------------------------------------------------
BC034872    Gpr18         G protein-coupled receptor 18
AK079337    Baalc         brain and acute leukemia, cytoplasmic
AK029205    V1rc15        vomeronasal 1 receptor, C15
AK031458    AI428795      expressed sequence AI428795
AB091829    MGI:2384865   O-acetyltransferase
AK085987    Mtr           5-methyltetrahydrofolate-homocysteine methyltransferase
AY277588    MGI:2668443   retinal short chain dehydrogenase reductase 2
AY317805    Olfr684       olfactory receptor 684
AK033012    Npat          nuclear protein in the AT region
AF357887    Dusp15        dual specificity phosphatase-like 15
AY073826    Olfr747       olfactory receptor 747
AY073750    Olfr1265      olfactory receptor 1265
AY073749    Olfr1495      olfactory receptor 1495
AY073644    Olfr1231      olfactory receptor 1231
AY073624    Olfr1261      olfactory receptor 1261
AY073578    Olfr530       olfactory receptor 530
AY073509    Olfr1030      olfactory receptor 1030
AY073501    Olfr703       olfactory receptor 703
AY073438    Olfr1131      olfactory receptor 1131
AY073304    Olfr1238      olfactory receptor 1238
AY073177    Olfr1377      olfactory receptor 1377
AF171073    Ppia          peptidylprolyl isomerase A
BC034068    BC034068      cDNA sequence BC034068
AK047412    AU020772      expressed sequence AU020772
BC049929    Ddx11         DEAD/H box polypeptide 11 (CHL1-like helicase homolog, S.
                          cerevisiae)
L38438      Ndufs6        NADH dehydrogenase (ubiquinone) Fe-S protein 6
The gene cluster displaying a weak decrease in relative mRNA levels early during lens regeneration compared to intact control lens.
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TABLE 12. Continued.
 GenBank
accession     Symbol                               Description
---------   -----------   -------------------------------------------------------------
AJ239052    Cryba1        Crystallin, beta A1
AK053869    Crybb1        Crystallin, beta B1
AJ272229    Crybb3        Crystallin, beta B3
Z22573      Crygb         Crystallin, gamma B
M64544      Crygc         Crystallin, gamma C
AJ224342    Crygd         Crystallin, gamma D
AF032115    Dnajc5        DnaJ (Hsp40) homolog, subfamily C, member 5
AF047542    Cyp2c37       Cytochrome P450, family 2. subfamily c, polypeptide 37
AF104312    Hao1          Hydroxyacid oxidase 1, liver
S67000      Hdc           Histidine decarboxylase
M81659      Hoxa10        Homeo box A10
U03562      Hspb1         Heat shock protein 1
BC002008    Fabp5         Fatty acid binding protein 5, epidermal
AF020772    Kpna3         Karyopherin (importin) alpha 3
AJ243857    Lhx9          LIM homeobox protein 9
AF099938    C1qr1         Complement component 1, q subcomponent, receptor 1
AK002719    Mocs2         Molybdenum cofactor synthesis 2
U36576      Nfatc2        Nuclear factor of activated T-cells, cytoplasmic,
                          Calcineurin-dependent 2
S83259      Nkx2-2        NK2 transcription factor related, locus 2 (Drosophila)
S81982      Nos1          Nitric oxide synthase 1, neuronal
U85786      Scn1b         Sodium channel, voltage-gated, type I, beta polypeptide
BC005434    Serpinb5      Serine (or cysteine) proteinase inhibitor, clade B, member 5
AY158991    Sprr2g        Small proline-rich protein 2G
U21110      Stat5b        Signal transducer and activator of transcription 5B
D14423      Tac2          Tachykinin 2
X52128      Tcp11         T-complex protein 11
U90889      Tkt           Transketolase
AK031386    D15Mit260     DNA Segment, Chr 15 Massachusetts Institute of Technology 260
AF302077    Mell1         Mel transforming oncogene-like 1
AY038025    Ngef          Neuronal guanine nucleotide exchange factor
AB021967    Igsf4a        Immunoglobulin superfamily, member 4A
AF334607    Dnase2b       Deoxyribonuclease II beta
AK003904    Slurp1        Secreted Ly6/Plaur domain containing 1
BC004057    Tacc2         Transforming, acidic coiled-coil containing protein 2
AF117382    Hic2          Hypermethylated in cancer 2
AF072881    Wsb2          WD repeat and SOCS box-containing 2
BC047277    Stk35         Serine/threonine kinase 35
AK002226    Lypdc2        Ly6/Plaur domain containing 2
AK006330    Gpr160        G protein-coupled receptor 160
AF320075    Nkg7          Matural killer cell group 7 sequence
AK012971    Lrriq2        Leucine-rich repeats and IQ motif containing 2
BC003884    Pacsin3       Protein kinase C and casein kinase substrate in neurons 3
AB037890    Sf3b1         Splicing factor 3b, subunit 1
BC004700    Klf7          Kruppel-like factor 7 (ubiquitous)
BC029689    Tdrd7         Tudor domain containing 7
BC022920    Dhx32         DEAH (Asp-Glu-Ala-His) box polypeptide 32
AJ304860    Bfsp2         Beaded filament structural protein 2, phakinin
AF391758    Vsx1          Visual system homeobox 1 homolog (zebrafish)
AF277385    MGI:2150387   Prostatic steroid binding protein C1
AF156979    Arr3          Arrestin 3, retinal
AB016768    MGI:2183426   Thrombospondin type 1 domain containing gene
BC032251    Bai3          Brain-specific angiogenesis inhibitor 3
AK080732    Kcnj14        Potassium inwardly-rectifying channel, subfamily J, member 14
M55171      Rho           Rhodopsin
BC024653    Oact1         O-acyltransferase (membrane bound) domain containing 1
AK089408    F730023N20    Hypothetical protein F730023N20
AK017800    Clic5         Chloride intracellular channel 5
AK037164    Eif5b         Eukaryotic translation initiation factor 5B
AF309072    Lctl          Lactase-like
AK032362    Usp32         Ubiquitin specific protease 32
L14569      Olfr144       Olfactory receptor 144
U08095      Krt1-12       Keratin complex 1, acidic, gene 12
BC029696    Dpp10         Dipeptidylpeptidase 10
The gene cluster displaying a strong uniform decrease in relative mRNA levels of regenerating lens compared to intact control lens.
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C:
                         Microarray          Quantitative real time PCR
                 ------------------------   ---------------------------
     Gene        Intact   2 week   3 week   Intact    2 week    3 week
--------------   ------   ------   ------   ------    ------   --------
 Disintegrin       1       2.69     1.93      1        1.29      1.54
 Timp1             1       2.62     2.75      1        8.56     10.87
 Btg1              1      -1.3      1.02      1        1.2       1.3
 Lysozyme          1       5.29     3.12      1        4.9       1.3
 Cdk8              1       1.62     1.46      1        1.33      1.49
 CNAp14            1       1.73     1.49      1        2.13      1.49
 SH3P7             1      -1.88    -1.46      1        0.56      0.73
 NO38              1       1.38     1.26      1        1.28      1.14
   γB-Crystallin     1      -1.53    -2.06      1        0.03      0.007
 Ceruloplasmin     1       4.01     2.39      1        1.77      2.04
Figure 4. QPCR analysis (A) of ten selected genes and the corresponding data from the microarray analysis (B). The expression values of lens
mRNA at 2 and 3 weeks post-surgery are compared with lens mRNA from the non-operated eye (value set at 1). C: The values between the two
methods.
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for low expressed genes are most likely more variable for over-
all poorly expressed genes than for highly expressed genes.
However, since we are using the statistical significance as the
main criteria for identifying differentially expressed genes,
such higher variability will be accounted for. That is, genes
with higher variability in observed ratios will have lower sta-
tistical significance than genes with low variability ratios.
Therefore, the statistical significance of low-expressed genes
has been implicitly adjusted in our analysis and the statisti-
cally significant genes have equal chance of being false posi-
tives regardless of the overall level of expression. Neverthe-
less, we also decided to test such genes. As seen in Figure 4,
expression of these genes as examined by QPCR was in ex-
cellent agreement with the microarray data. The housekeep-
ing gene ATP synthase, epsilon subunit was used as the refer-
ence. This gene was found to have no differential expression
in our microarray analysis and showed no differential expres-
sion in the QPCR experiments as well.
The mouse model for lens regeneration that we have de-
scribed previously [6] is a valuable one because both EMT
and lens fiber differentiation take place. Specifically, while
the capsular bag is filled gradually with fibers, EMT is seen
during the early stages and diminishes later. This has led us to
utilize this model and examine global gene expression in or-
der to associate clustered genes with both processes and iden-
tify new genes and networks. The availability of mutant mice
will supplement these studies. By extensive genomic studies
with mice lacking genes involved in EMT or lens fiber differ-
entiation, the patterns of gene expression reported in this study
could be sorted out in order to identify the role and regulation
of known and novel genes involved in these processes. Exten-
sion of these studies, therefore, will lead to the establishment
of databases and will provide indispensable and long-sought
animal models for approaching PCO at the genetic level. At
the same time, these studies will complement databases re-
lated to ocular bioinformatics [28-34].
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